Article Details

Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer ...

Retrieved on: 2021-06-23 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer .... View article details on hiswai:

Excerpt

Immunicum's relapse vaccine candidate contains allogeneic dendritic cells that can boost various key elements of the immune system against multiple ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo